Tarsons Products Ltd - 543399 - Re-Submission Of Initial Disclosure In Annexure-A Given Under The Circular SEBI/HO/DDHS/CLR/P/2018/144 Dated November 26, 2018
In context to the above captioned subject, we hereby re-submit the Initial Disclosure in terms of SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated 26th November, 2018 as advised vide your email dated 4th March, 2023. Tarsons Products Ltd - 543399 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst/ Institutional Investor Meeting(s) pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Tarsons Products Ltd - 543399 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Transcript of Earnings Call. Tarsons Products Ltd - 543399 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Tarsons Products Ltd - 543399 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Report of the Monitoring Agency w.r.t. Utilization of Proceeds of the Initial Public Offer of Tarsons Products Limited ('the Company') for the quarter ended 31st December, 2022 Tarsons Products Ltd - 543399 - Statement Of Deviation Or Variation In The Use Of Proceeds Of Initial Public Offer Of Tarsons Products Limited For The Quarter Ended 31St December, 2022
Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular CIR/CFD/CMD1/162/2019 dated December 24, 2019, we request you to note that there are no deviation(s) or variation(s) in respect of utilization of proceeds of Initial Public Offer of the Company for the quarter ended 31st December, 2022, as mentioned in the object clause of the offer letter of the issue. In this regard, please find enclosed herewith the said statement. The aforesaid statement will also be available on the Company's website at www.tarsons.com. Tarsons Products Ltd - 543399 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of Financial Results for third quarter and nine months ended 31st December, 2022. Tarsons Products Ltd - 543399 - Audio Recording Of Investors Conference Call
In continuation to our letter dated 2nd February, 2023 regarding intimation of Investors/Analyst conference call on the Unaudited Financial Results of the Company for the third quarter and nine months ended 31st December, 2022, we would like to inform you that the audio recording of the said call has been uploaded on the Company's website. This can be accessed via the following link. Link: https://tarsons.com/wp-content/uploads/2023/02/Tarsons-Products-Limited-Q3-FY23-Earnings-Call-Audio.mp3 Q3FY23 Quarterly Result Announced for Tarsons Products Ltd.
Plastic products firm Tarsons Products announced Q3FY23 results: Q3FY23 & 9MFY23: Revenues for Q3FY23 & 9MFY23 were lower by 13% & 7% respectively, dip in revenues was on account of: Temporary slowdown in the life science industry, since the industry is yet recovering from the after-effects of the covid pandemic. Loss in revenues related to covid pandemic as compared to the previous financial year, however, our conventional business revenues have shown resilience & are expected to pick up. EBITDA margins for the Q3FY23 stood at 43.5% & for 9MFY23 stood at 45%,dip in the margins were on account of: Lower absorption of fixed cost on account of decline in revenues Higher spends on sales promotion, marketing & travelling expenses to fuel future growth in domestic & export markets. Update on our upcoming Capex (New manufacturing capacities at Panchla, West Bengal): Capex plan is as per the schedule and we do not see any major deviation from our timelines. We remain optimistic about the industry growth prospects, with the addition of new product categories & capacity expansion we envisage reaching greater heights. Manufacturing at the new facilities will begin in phases starting from Q2FY24. Commenting on the Q3 FY23 performance of the company Mr. Rohan Sehgal, Whole Time Director for Tarsons, said: “Our revenues for Q3FY23 were lower by 13% on a YoY basis, this decline was majorly attributable to external macro-economic factors & overall slow down in the life science industry. Impact on revenues was also on account of high base of covid related revenues in FY22, which was replaced by our conventional business to a significant extent in the current financial year. Due to political uncertainty and growing recessionary trends, our export revenues declined by 17% during the quarter and remained flat for 9MFY23. These are difficult times for not only our industry, but for the entire world, and we are standing firm and attempting to sail through these challenging times. Our capacity expansion is proceeding smoothly, and commissioning is scheduled for Q2FY24. These capabilities would propel the company's next phase of expansion, which would include the addition of high-value products, which would further strengthen the "Tarsons" brand. We believe that these market conditions are temporary in nature and in the long term we see the plastic labware market continue to grow both domestically and internationally and so will Tarsons.” Result PDF Tarsons Products Ltd - 543399 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Investor Presentation on the Operational & Financial Highlights for the quarter ended 31st December, 2022. The Presentation will also be uploaded on the Company's website at www.tarsons.com.